col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


56 Results       Page 1

 [1] 
Ovid: Journal of Addiction Medicine
  original article Date Title Authors   All Authors
1 [GO] 2022―Mar―11 HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic During a Local HIV Outbreak at the Onset of the COVID-19 Pandemic Hannan M. Braun, Chelsea Walter, Natalija Farrell, Katie B. Biello, Jessica L. Taylor
2 [GO] 2022―Feb―23 Patient Characteristics Associated With Phone Versus Video Telemedicine Visits for Substance Use Treatment During COVID-19 Ji Eun Chang, Zoe Lindenfeld, Tatiana Thomas, Justine Waldman, Judith Griffin
3 [GO] 2022―Feb―15 Changes in Cannabis Use Risk Behaviors During the First and Second COVID-19 Lockdown in Israel Sharon R. Sznitman
4 [GO] 2022―Feb―15 Shifting Medication Treatment Practices in the COVID-19 Pandemic Noa Krawczyk, Hannah Maniates, Eric Hulsey, Jennifer S. Smith, Ellen DiDomenico, Elizabeth A. Stuart, et al. (+2)
5 [GO] 2022―Feb―12 Supporting Self-isolation for COVID-19 With “Risk Mitigation” Prescribing and Housing Supports for People Who Use Drugs Ran Ha Hong, Rupinder Brar, Nadia Fairbairn
6 [GO] 2022―Feb―04 A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic Alyssa F. Peterkin, Rohit Abraham, Miriam T.H. Harris
7 [GO] 2022―Jan―12 Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic Minhee L. Sung, Anne C. Black, Derek Blevins, Brandy F. Henry, Kathryn Cates-Wessel, Michael A. Dawes, et al. (+6)
8 [GO] 2021―Nov―18 Factors Associated With Increased Opioid Use During the COVID-19 Pandemic Tea Rosic, Leen Naji, Nitika Sanger, David C. Marsh, Andrew Worster, Lehana Thabane, Zainab Samaan
9 [GO] 2021―Jun―26 During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio Jamie Vieson, Arthur B. Yeh, Qizhen Lan, Jon E. Sprague
10 [GO] 2021―Jun―19 Harnessing the Power of Social Media to Understand the Impact of COVID-19 on People Who Use Drugs During Lockdown and Social Distancing Nabila El-Bassel, Karli R. Hochstatter, Melissa N. Slavin, Chenghao Yang, Yudong Zhang, Smaranda Muresan
11 [GO] 2021―May―04 The Role of Alcohol Biomarkers in Detecting a Physician's COVID-19-Related Acute Stress Response Alexis G. Polles, William S. Jacobs, Chad Brazle, Lisa J. Merlo
12 [GO] 2021―Apr―26 Social Determinants of Mortality of COVID-19 and Opioid Overdose in American Rural and Urban Counties Yuhui Zhu, Zhe Fei, Larissa J. Mooney, Kaitlyn Huang, Yih-Ing Hser
13 [GO] 2021―Apr―20 Opioid-related Emergency Department Visits During COVID-19 in a Large Health System Gavin T. Hall, Daniel S. Cruz, Patrick M. Lank, Danielle M. McCarthy, Howard S. Kim
14 [GO] 2021―Apr―20 Virtual Twelve Step Meeting Attendance During the COVID-19 Period Marc Galanter, William L. White, Brooke Hunter
15 [GO] 2021―Apr―12 Barriers to Care Experienced by Patients Who Inject Drugs During the COVID-19 Pandemic Emily Gleason, Nathanial S. Nolan, Laura R. Marks, Tracey Habrock, Stephen Y. Liang, Michael J. Durkin
16 [GO] 2021―Mar―26 The Relationship Between Children's Problematic Internet-related Behaviors and Psychological Distress During the Onset of the COVID-19 Pandemic Chao-Ying Chen, I-Hua Chen, Wen-Li Hou, Marc N. Potenza, Kerry S. O’Brien, Chung-Ying Lin, Janet D. Latner
17 [GO] 2021―Mar―24 Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic Lila Flavin, Babak Tofighi, Noa Krawczyk, Daniel Schatz, Jennifer McNeely, Jenna Butner
18 [GO] 2021―Feb―27 Low-Threshold Buprenorphine via Community Partnerships and Telemedicine-Case Reports of Expanding Access to Addiction Treatment During COVID-19 Ximena A. Levander, Haven Wheelock, Justine Pope, Abby Lee, Kerith Hartmann, Sarah Abuelkhair, et al. (+2)
19 [GO] 2021―Feb―21 Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis Andrew S. Huhn, Eric C. Strain, Jasmyne Jardot, Gavin Turner, Cecilia L. Bergeria, Sandeep Nayak, Kelly E. Dunn
20 [GO] 2021―Feb―21 Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication John W. McIlveen, Kim Hoffman, Kelsey C. Priest, Dongseok Choi, Phillip Todd Korthuis, Dennis McCarty
21 [GO] 2021―Feb―06 Factors Associated With Drug Overdoses During the COVID-19 Pandemic Alexandra M. Mellis, Braeden C. Kelly, Marc N. Potenza, Jessica N. Hulsey
22 [GO] 2020―Dec―15 Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19 A. Taylor Kelley, Matthew T. Dungan, Adam J. Gordon
23 [GO] 2020―Dec―15 COVID-19 and Cannabidiol (CBD) Jag H. Khalsa, Greg Bunt, Sanjay B. Maggirwar, Shyam Kottilil
24 [GO] 2020―Dec―15 Cannabis Use During the COVID-19 Pandemic in Canada Sameer Imtiaz, Samantha Wells, Jürgen Rehm, Hayley A. Hamilton, Yeshambel T. Nigatu, Christine M. Wickens, et al. (+2)
25 [GO] 2020―Dec―15 Impacts of the COVID-19 Shutdown on Gambling Patterns in Australia Sally M. Gainsbury, Thomas B. Swanton, Martin T. Burgess, Alex Blaszczynski
26 [GO] 2020―Dec―15 COVID-19 Social Distancing and Online Mutual Help Engagement for Alcohol Use Recovery Jason B. Colditz, Scott D. Rothenberger, Jane M. Liebschutz, Bruce L. Rollman, Kevin L. Kraemer
27 [GO] 2020―Dec―10 Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic Miriam Komaromy, Mary Tomanovich, Jessica L. Taylor, Glorimar Ruiz-Mercado, Simeon D. Kimmel, Sarah M. Bagley, et al. (+6)
28 [GO] 2020―Nov―24 Treating Opioid Use Disorder in Puerto Rico During the COVID-19 Pandemic Darlene Santiago Quiñones, Kyle Melin, Luis Roman, Francisco Rodriguez, Jose Alvarado, Carlos E. Rodríguez-Díaz
29 [GO] 2020―Nov―19 The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose Alexandra B. Collins, Francesca L. Beaudoin, Elizabeth A. Samuels, Rachel Wightman, Janette Baird
30 [GO] 2020―Nov―11 Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic Courtney D. Nordeck, Megan Buresh, Noa Krawczyk, Michael Fingerhood, Deborah Agus
31 [GO] 2020―Nov―06 The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities Erin Stack, Gillian Leichtling, Jessica E. Larsen, Mary Gray, Justine Pope, Judith M. Leahy, et al. (+3)
32 [GO] 2020―Nov―04 Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies Derek D. Satre, Esti Iturralde, Murtuza Ghadiali, Kelly C. Young-Wolff, Cynthia I. Campbell, Amy S. Leibowitz, Stacy A. Sterling
33 [GO] 2020―Oct―26 Rapid Transition of Individual and Group-based Behavioral Outpatient Visits to Telepsychiatry in Response to COVID-19 Erin L. Winstanley, Laura R. Lander, Wanhong Zheng, Kari-Beth Law, Ashley Six-Workman, James H. Berry
34 [GO] 2020―Oct―26 Alcohol Consumption in Response to the COVID-19 Pandemic in the United States Carolina Barbosa, Alexander J. Cowell, William N. Dowd
35 [GO] 2020―Oct―08 Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic David C. Cone, Sandy Bogucki, Kevin Burns, Gail D’Onofrio, Kathryn Hawk, Daniel Joseph, David A. Fiellin
36 [GO] 2020―Oct―08 Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas James Douglas Thornton, Tyler J. Varisco, Shweta S. Bapat, Callie G. Downs, Chan Shen
37 [GO] 2020―Oct―06 MOUD Provision in Correctional Settings During Time of COVID-19 Nickolas Zaller, Lauren Brinkley-Rubinstein
38 [GO] 2020―Oct―03 Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs MJ Stowe, Tanya Calvey, Florian Scheibein, Sidharth Arya, Noha Ahmed Saad, Tomohiro Shirasaka, et al. (+16)
39 [GO] 2020―Oct―03 Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing Jonathan Cantor, Bradley D. Stein, Brendan Saloner
40 [GO] 2020―Sep―20 Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19 Christina A. Brezing, Sean X. Luo, John J. Mariani, Frances R. Levin
41 [GO] 2020―Sep―16 Preferences for Tobacco Cessation Information and Support During Covid-19 Simone Pettigrew, Min Jun, Ian Roberts, Chris Bullen, Kellie Nallaiah, Anthony Rodgers
42 [GO] 2020―Sep―09 The Changing Landscape of Alcohol Use and Alcohol Use Disorder During the COVID-19 Pandemic - Perspectives of Early Career Professionals in 16 Countries Tanya Calvey, Florian Scheibein, Noha Ahmed Saad, Tomohiro Shirasaka, Lisa Dannatt, MJ Stowe, et al. (+16)
43 [GO] 2020―Aug―30 Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons Sachini Bandara, Alene Kennedy-Hendricks, Sydney Merritt, Colleen L. Barry, Brendan Saloner
44 [GO] 2020―Aug―27 A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic Caroline P. Meehan, Rachel S. Wightman
45 [GO] 2020―Aug―21 Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond Coleman Drake, Jiani Yu, Nicole Lurie, Kevin Kraemer, Daniel Polsky, Krisda H. Chaiyachati
46 [GO] 2020―Aug―08 Opioid Use Disorder in the Emergency Department Amid COVID-19 Lauren A. Walter, Li Li
47 [GO] 2020―Aug―08 Calls for Access to Safe Injecting Supplies as a Critical Public Health Measure During the COVID-19 Pandemic Koharu Loulou Chayama, Cara Ng, Ryan McNeil
48 [GO] 2020―Jun―24 COVID-19 as a Frying Pan Brandon del Pozo, Leo Beletsky, Josiah D. Rich
49 [GO] 2020―Jun―11 Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA Joshua A. Barocas, Elizabeth Blackstone, Tara C. Bouton, Simeon D. Kimmel, Andrea Caputo, Sarah J. Porter, Alexander Y. Walley
50 [GO] 2020―Jun―01 Will the Current COVID-19 Pandemic Impact on Long-Term Cannabis Buying Practices? Teodora Groshkova, Tiberiu Stoian, Andrew Cunningham, Paul Griffiths, Nicola Singleton, Roumen Sedefov
51 [GO] 2020―May―26 Low Barrier Tele-Buprenorphine in the Time of COVID-19 Miriam Harris, Samantha Johnson, Sarah Mackin, Richard Saitz, Alexander Y. Walley, Jessica L. Taylor
52 [GO] 2020―May―26 Gambling during the COVID-19 crisis - A cause for concern? Anders Håkansson, Fernando Fernández-Aranda, Jose M. Menchón, Marc N. Potenza, Susana Jiménez-Murcia
53 [GO] 2020―May―26 Opioid Policy Changes During the COVID-19 Pandemic - and Beyond Corey S. Davis, Elizabeth A. Samuels
54 [GO] 2020―May―14 Innovation During COVID-19 Elizabeth A. Samuels, Seth A. Clark, Caroline Wunsch, Lee Ann Jordison Keeler, Neha Reddy, Rahul Vanjani, Rachel S. Wightman
55 [GO] 2020―May―14 Opioid Use Disorder and COVID-19 Utsha G. Khatri, Jeanmarie Perrone
56 [GO] 2020―May―14 Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2) Idris E. Leppla, Marielle S. Gross
 [1] 

56 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec